Skip to content

भाषा बदलें: हिंदी में

mTatva Health-PIE

Search for:

Home
Health Articles
Disease Facts
Drug Facts – Brands
Drug Facts – Generics

Category: ANTI-CTLA-4 MONOCLONAL ANTIBODIES

Drug Classification

IPILIMUMAB

September 13, 2018 mTatva Health

IPILIMUMAB is a Schedule H drug.

ANTI-CTLA-4 MONOCLONAL ANTIBODIESmedicine for kidney cancer, medicine for melanoma

Like us

Top Posts & Pages

ME 12 OD TAB
Polio: Symptom and Causes
Sick Building Syndrome: Treatment, Diet and Home Remedies
Sick Building Syndrome: Symptom and Causes
Diphtheria: Treatment, Diet and Home Remedies
MICROMOL P TAB
SETRAL 50MG TAB
ULTRAM 325MG/37.5MG TAB
Hepatitis C: Meaning, Diagnosis and Overview
Set medicine reminders and monitor dose in-take for your loved ones remotely

Recent Posts

Games changers of Healthcare – AI and IoMT
ULTRAMED 325MG/37.5MG TAB
ULTRAM 325MG/37.5MG TAB
ULTRAGIN 500MG TAB
ULTRACET SEMI 162.5MG/18.75MG TAB
ULTRACET 325MG/37.5MG TAB
ULTRABEST 37.5MG/325MG TAB
ULTRA PLUS H 162.5MG/18.75MG TAB
ULTRA PLUS 325MG/37.5MG TAB
ULTIMIDE 750MG TAB
ULTIFIX PLUS TAB
ULTIFIX LB TAB
ULTIFIX CV 250MG/125MG TAB
ULTIFIX 50MG TAB DT
ULTIFIX 50MG DRY SYP
ULTIFIX 200MG TAB DT
ULTIFIX 100MG TAB DT
ULTICAN 150MG TAB
ULEEV 250MG TAB
UCO 150MG TAB

1 2 3 100MG TAB
1 2 3 25MG TAB
1 2 3 50MG TAB
1 AL 10MG TAB
1 AL 2.5MG SYP

Home
Health Articles
Disease Facts
Drug Facts – Brands
Drug Facts – Generics

Copyright Since 2013. All rights reserved @mTatva

Proudly powered by WordPress | Education Hub by WEN Themes

X

Your Personal Doctor on Mobile
Get 1000+ diseases comprehensive information on your mobile

Download App Now